Thoracic procedures bring together mobile organs, delicate tissue planes and anatomy that must continue functioning immediately after surgery.
Evologics provides human tissue products for surgeon-directed wound coverage and selected soft-tissue reconstruction across open, minimally invasive and robotic thoracic environments.
EvoPatch is a sterile, double-layer human amniotic membrane allograft intended for use as a wound covering.
Its continuous, conformable sheet format may be considered at selected surgical sites in procedures involving the esophagus, lung, mediastinum, pericardium, sternum or conduit-harvest area.
EvoPatch is omni-directional and may be used dry or hydrated according to clinician preference and the current Instructions for Use.
Human pericardial allograft provides a naturally dense soft-tissue configuration for selected repair, patching or reconstruction applications when consistent with the product’s controlled labeling.
EvoDerm is a human dermis-derived allograft that may be evaluated in selected chest-wall and soft-tissue reconstruction procedures.
Product selection should account for defect geometry, required handling characteristics, fixation method and institutional protocol.
A-MATRX offers an alternative amniotic tissue geometry for focused areas, curved surfaces and confined thoracic spaces where a continuous sheet may not fit the surgical plan.
The portfolio may be discussed in connection with:
Evologics provides product documentation, handling resources, tissue-tracking support, facility review materials and coordination with the local representative.
Product information, specifications, IFUs, evidence and facility needs.
Value-analysis support, regulatory documentation, pricing and product comparison.
Ordering workflow, onboarding, staff education and initial coordination.
Clinical education, representative support, replenishment and follow-up.
Procedure examples are provided for general informational and navigation purposes. They do not establish a product indication, treatment recommendation or expected clinical outcome.
Product selection, preparation, placement and documentation remain the responsibility of the qualified healthcare professional and facility. Use must be consistent with the current Instructions for Use, product labeling, institutional policy and applicable regulatory requirements.
Where website language differs from a controlled product document, the current controlled document governs.
Request product information or schedule a portfolio review.